MedTrace Logo

Digital Health for Caregivers Emotional and Self-management Support

NCT04812665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2023-03-29

No results posted yet for this study

Summary

This feasibility study builds upon mental health and technology acceptance theoretical frameworks. It seeks to examine potentials of a novel mobile Health (mHealth) solution based on emotional and behavioral change techniques, to provide emotional and self-management tailored support to caregivers of children undergoing Growth Hormone treatment (GHt).

Conditions

  • Emotional Adjustment
  • Mood Disturbance

Interventions

BEHAVIORAL

mHealth solution based on emotional and behavioral change techniques

Adhera supports the empowerment of patients with chronic conditions by supporting the acquisition of healthier lifestyles, improved mental wellbeing and grounded on the principles of behavioral change. The solution is based on incorporating the principles of personalized health education into a mobile platform which is achieved by applying the Integrated Model of Behavioral Change which is further adapted using recommender systems. Emotional and mental health elements, such as stress, resilience, are crucial part in the acquisition of self-management behaviors and will be the main focus of this intervention. Adhera adapts to provide tailored support to specific users' needs.

Sponsors & Collaborators

  • Hospital Miguel Servet

    collaborator OTHER

  • Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

    collaborator INDUSTRY

  • Adhera Health, Inc.

    lead INDUSTRY

Principal Investigators

  • Luis Fernández-Luque, PhD · Adhera Health, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-17
Primary Completion
2022-08-12
Completion
2022-08-12

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04812665 on ClinicalTrials.gov